Versuchen GOLD - Frei
Patient-Centric Innovation – Catering To Future Needs
Express Pharma
|December 16-31, 2019
Manoj Saxena, Managing Director, Bayer Zydus Pharma, talks about how technology has become an essential tool that complements the personal and physical interaction with a healthcare professional to help patients lead a healthier life
-
William Osler, the Father of Modern Medicine said – ‘A good physician treats the disease; a great physician treats the patient.’ To me, this succinctly explains the benefits of putting patients at the centre of treatment and for this, patient-centric innovation, that prioritizes the safety and well-being of patients is fundamental.
Over the past years, the healthcare industry has been witnessing a seismic shift in the way it has approached treatment and diagnosis. Today, the patient is the pivot around which innovations occur, be it in R&D or using technology to ensure healthcare is simplified and accessible. The new approach is also more focussed on ‘prevention’ wherein the industry is now looking at delivering holistic end-to-end healthcare solutions.
Shift in healthcare demographics is fundamentally defining how the healthcare industry needs to engage with the consumer/patient. India has more than 600 million young people and how they look at healthcare is going to define the very future of this industry. India also has a huge aging population and this will lead to an industry focus on specific solutions catering to the segment of ‘healthy aging’.
In our patient-centric approach, Bayer has kept the millennials as well as the aging population in mind as it moves towards developing novel solutions based on the principles of technology, artificial intelligence (AI), biomarkers and/or robotics among others. Technology is now an essential tool that complements the personal and physical interaction with a healthcare professional (HCP) to help patients lead a healthier life and it will continue to play an increasingly important role in the future.
Diese Geschichte stammt aus der December 16-31, 2019-Ausgabe von Express Pharma.
Abonnieren Sie Magzter GOLD, um auf Tausende kuratierter Premium-Geschichten und über 9.000 Zeitschriften und Zeitungen zuzugreifen.
Sie sind bereits Abonnent? Anmelden
WEITERE GESCHICHTEN VON Express Pharma
Express Pharma
Speed and flexibility play a critical role in how we compete with larger global players
Kriti Jajoo, VP-BD and Strategy, Shriji Polymers, as the next-gen leader, speaks on how the company is evolving with a leadership approach that balances technology, sustainability, and customer-centricity to create long-term value, in an interview with Express Pharma
6 mins
January 2026
Express Pharma
Vizag rising: Shaping India's pharma future
At the Vizag Pharma Summit 2025, hosted by Express Pharma, industry leaders discussed how quality, R&D, compliance, and emerging technologies are driving India's next phase of pharma growth
9 mins
January 2026
Express Pharma
Future of pharma: Trends, challenges & AI
Industry experts discussed how Al is transforming pharmaceutical R&D, highlighting both the promise and the practical limitations of current technologies
2 mins
January 2026
Express Pharma
Gandhi Automations presents multi-composites, high-performance door PRIME NEO for clean environments
When it comes to pharmaceutical facilities and laboratories, clean rooms' hygiene and protection from environmental contamination are the most important factors to consider.
1 mins
January 2026
Express Pharma
Can Indian biosimilars and generics restate accessibility in global underserved markets?
Hari Kiran Chereddi, MD & CEO - HRV Pharma & NHG Pharma highlights that India's success in generics is no longer enough, as the world now demands advanced biologics, biosimilars, and personalised medicines. He further emphasises on the need for stronger regulation, innovation, and investment so India can lead in next-generation therapies and expand global access to cutting-edge healthcare
3 mins
January 2026
Express Pharma
The next wave of growth will belong not to the fastest manufacturers but to the most innovative problem-solvers
As India moves into 2026, industry experts state that the next phase of growth in pharmaceuticals will depend on strengthening formulation R&D, building a skilled and adaptable workforce, and closing gaps between academic research and industry needs.
6 mins
January 2026
Express Pharma
Results win customers. Leadership discipline keeps them
Drawing themes from his new book The Dual Mandate in B2B - Driving Results. Shaping Culture, Mohan Joshi - Global C-Suite Partner & Former President, SCHOTT India, discusses leadership systems, alignment, and execution in conversation with Neha Aathavale.
3 mins
January 2026
Express Pharma
INDIA'S INNOVATION JOURNEY FROM PROMISE TO PROOF
India's pharma ecosystem is ready to embrace stronger science and bolder ideas. Turning early breakthroughs into scalable, sustainable innovation remains the challenge
8 mins
January 2026
Express Pharma
PRUV® -The original Sodium Stearyl Fumarate
JRS Pharma's PRUV® is the original sodium stearyl fumarate (SSF) introduced in the market over 20 years ago
5 mins
January 2026
Express Pharma
Odisha's pharma pitch
The inaugural Odisha Pharma Summit 2025 delivered strong early signals of intent, positioning the state as an upcoming destination for PLI-triggered expansions, to complement existing pharma hubs. As Hemant Sharma, ACS Industry Dept and I&PR Dept, Govt of Odisha puts it, the aim is to “become a good, viable second option.” How fast can the eastern newcomer catch up and become India's next life sciences hub, asks Viveka Roychowdhury
5 mins
January 2026
Translate
Change font size
